NCT07050095View on ClinicalTrials.gov

Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Anxiolytic EffectVirtual Reality ImmersionMidazolamPremedicationDacryocystorhinostomy
Interventions
OTHER

Virtual Reality Group

Patient will undergo virtual reality (VR) immersion using oculus.

DRUG

Midazolam Group

Patient will receive midazolam premedication only.

Trial Locations (1)

12613

RECRUITING

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER